The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells.

[1]  H. Adlercreutz,et al.  Plasma concentrations of phyto-oestrogens in Japanese men , 1993, The Lancet.

[2]  Z. Darżynkiewicz,et al.  Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. , 1992, Cancer research.

[3]  A. Murray,et al.  Creative blocks: cell-cycle checkpoints and feedback controls , 1992, Nature.

[4]  H. Crissman,et al.  Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Workman.  Signal transduction inhibitors as novel anticancer drugs: where are we? , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  M. Schwab,et al.  Identification in human urine of a natural growth inhibitor for cells derived from solid paediatric tumours , 1992, European journal of clinical investigation.

[7]  M. Lavin,et al.  Specific protein dephosphorylation in apoptosis induced by ionizing radiation and heat shock in human lymphoid tumor lines. , 1992, Journal of immunology.

[8]  Z. Darżynkiewicz,et al.  Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells. , 1992, Cancer research.

[9]  H. Adlercreutz,et al.  Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. , 1991, The American journal of clinical nutrition.

[10]  I. Nicoletti,et al.  Inhibition of human breast cancer cell (MCF-7) growth in vitro by the somatostatin analog SMS 201-995: effects on cell cycle parameters and apoptotic cell death. , 1991, Endocrinology.

[11]  H. Crissman,et al.  Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Barnes,et al.  Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. , 1991, Biochemical and biophysical research communications.

[13]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[14]  Z. Darżynkiewicz,et al.  Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells. , 1991, Cancer research.

[15]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[16]  Michael Cross,et al.  Growth factors in development, transformation, and tumorigenesis , 1991, Cell.

[17]  G. Schieven,et al.  Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Sorenson,et al.  Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. , 1990, Journal of the National Cancer Institute.

[19]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[20]  T. Sakai,et al.  The effect of quercetin on cell cycle progression and growth of human gastric cancer cells , 1990, FEBS letters.

[21]  L. Hartwell,et al.  Checkpoints: controls that ensure the order of cell cycle events. , 1989, Science.

[22]  A. Murray.  The cell cycle as a cdc2 cycle , 1989, Nature.

[23]  M. Cyert,et al.  Putting it on and taking it off: Phosphoprotein phosphatase involvement in cell cycle regulation , 1989, Cell.

[24]  A. Schally,et al.  Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Yoshinari,et al.  Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells. , 1988, Biochemical and biophysical research communications.

[26]  M. Shibuya,et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.

[27]  J. Ishida,et al.  A specific inhibitor for tyrosine protein kinase from Pseudomonas. , 1986, The Journal of antibiotics.

[28]  D. N. Kirk,et al.  Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. , 1984, The American journal of clinical nutrition.

[29]  F. Marks,et al.  Inhibition of the calcium- and phospholipid-dependent protein kinase activity from mouse brain cytosol by quercetin. , 1983, Biochemical and biophysical research communications.

[30]  J. Gray,et al.  Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Maclennan,et al.  Quercetin interaction with the (Ca2+ + Mg2+)-ATPase of sarcoplasmic reticulum. , 1981, The Journal of biological chemistry.

[32]  E. Racker,et al.  Inhibition of lactate transport and glycolysis in Ehrlich ascites tumor cells by bioflavonoids. , 1979, Biochemistry.

[33]  Y. Graziani.  Bioflavonoid regulation of ATPase and hexokinase activity in Ehrlich ascites cell mitochondria. , 1977, Biochimica et biophysica acta.

[34]  J. Gee,et al.  Inhibition of 2-deoxy-D-glucose transport by theophylline, caffeine and papaverine in alveolar macrophages. , 1974, Biochemical pharmacology.

[35]  S. Barnes,et al.  Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation , 1993, The Prostate.

[36]  C. Riccardi,et al.  Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. , 1993, European journal of cancer.

[37]  J. Le Pecq,et al.  Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. , 1990, Biochemical pharmacology.

[38]  V. Groppi,et al.  Cell cycle specific inhibitors. , 1989, Pharmacology & therapeutics.

[39]  A. Ullrich,et al.  Growth factor receptor tyrosine kinases. , 1988, Annual review of biochemistry.

[40]  T. Hunter,et al.  Regulation of cell growth and transformation by tyrosine-specific protein kinases: the search for important cellular substrate proteins. , 1983, Current topics in microbiology and immunology.

[41]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.